Inhalation delivery of asthma drugs
β Scribed by Heinrich Matthys
- Book ID
- 110650685
- Publisher
- Springer
- Year
- 1990
- Tongue
- English
- Weight
- 403 KB
- Volume
- 168
- Category
- Article
- ISSN
- 0341-2040
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
## Abstract Pulmonary tuberculosis is associated with a yearβlong chemotherapy, poor alveolar drug levels, drugβrelated systemic toxicity, and patient noncompliance. In this study, exogenous pulmonary surfactant is proposed as a drug carrier for antitubercular drugs. Dipalmitoylphosphatidylcholine
Inhaled corticosteroids reduce asthma symptoms and exacerbations, improve lung function, and reduce airway inflammation and bronchial hyperreactivity more effectively than other treatments. However, inhaled corticosteroids may be unable to return lung function and bronchial hyperreactivity to normal